Clinilabs

Clinilabs opens phase I unit in New Jersey

Tuesday, May 29, 2012 03:25 PM

New York-based Clinilabs, an early phase and specialty CRO, has opened a second phase I unit in southern New Jersey. The 50-bed capacity, 15,000-square-foot Specialty Pharma Phase I Unit features semi-private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy and exam rooms.

More... »

Clinilabs selects NewCardio's QTinnoŽ solution for phase I trial

Thursday, November 10, 2011 08:12 AM

NewCardio, a cardiovascular diagnostic solutions developer, has reported that its strategic partner, Clinilabs, will utilize QTinnoŽ, NewCardio's automated cardiac safety solution, to conduct a phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.

More... »

Clinilabs selected for investigational medication study

Friday, July 15, 2011 10:43 AM

CRO Clinilabs has been selected to conduct a clinical research study on the effects of an investigational medication on the sleep of healthy volunteers.

More... »

Clinilabs selected for phase II study

Friday, June 10, 2011 11:53 AM

New York-based CRO Clinilabs has been selected to conduct a phase II clinical research study of an investigational medication in patients with Major Depressive Disorder.

More... »

Clinilabs chosen for COPD trial

Wednesday, April 27, 2011 02:34 PM

CRO Clinilabs, a company that provides early-stage and clinical drug development services, has been selected to conduct a phase I clinical research study of an investigational medication in patients with chronic obstructive pulmonary disease (COPD).

More... »

Clinilabs selected for a phase I study in patients with OSA

Wednesday, April 20, 2011 11:44 AM

Clinilabs, a CRO that provides early-stage and clinical drug development services to industry, has been selected to conduct a phase I clinical research study of an investigational medication in patients with Obstructive Sleep Apnea (OSA).

More... »

Clinilabs Partners with Renal Research Institute

Wednesday, February 10, 2010 07:12 AM

New York-based contract research organization (CRO) Clinilabs recently announced a collaboration with the Renal Research Institute (also headquartered in New York) to conduct studies in patients with renal impairment.

More... »

Clinilabs Launches New Document Management System

Thursday, February 4, 2010 07:02 AM

New York-based contract research organization (CRO) Clinilabs released its own document management system that the company said will significantly reduce the cost of information management and clinical monitoring and auditing during clinical trials.

More... »

Clinilabs Names Greenberg Director of Expanded Unit

Wednesday, November 26, 2008 06:00 AM

New York, NY-based contract research organization (CRO) Clinilabs appointed Howard Greenberg, M.D., senior medical director of the company’s newly expanded clinical pharmacology unit. Greenberg has served as the principal investigator or co-investigator for more than 100 clinical trials and co-authored more than 30 peer-reviewed research publications. Most recently, he was group medical director at Bristol-Meyers Squibb.

More... »

Clinilabs Boosts Phase I Capacity, Looks for More Growth

Monday, August 18, 2008 09:00 AM

New York, N.Y.-based Clinilabs, a specialty contract research organization (CRO), has completed expansion of its phase I unit to 68 beds, including two new large observation rooms that can accommodate up to four beds each.

More... »